193 related articles for article (PubMed ID: 25656940)
1. Ceruloplasmin is Involved in the Nigral Iron Accumulation of 6-OHDA-Lesioned Rats.
Wang J; Bi M; Xie J
Cell Mol Neurobiol; 2015 Jul; 35(5):661-8. PubMed ID: 25656940
[TBL] [Abstract][Full Text] [Related]
2. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.
Wang J; Jiang H; Xie JX
Eur J Neurosci; 2007 May; 25(9):2766-72. PubMed ID: 17561842
[TBL] [Abstract][Full Text] [Related]
3. Transplanted Neural Stem Cells: Playing a Neuroprotective Role by Ceruloplasmin in the Substantia Nigra of PD Model Rats?
Xiao JJ; Yin M; Wang ZJ; Wang XP
Oxid Med Cell Longev; 2015; 2015():618631. PubMed ID: 26146528
[TBL] [Abstract][Full Text] [Related]
4. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease.
Song N; Wang J; Jiang H; Xie J
Free Radic Biol Med; 2010 Jan; 48(2):332-41. PubMed ID: 19913091
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of α-lipoic acid promoting iron efflux in substantia nigra cells of Parkinson's disease rats].
Cai T; Wei C; Zhai S; Tai S; Zhang C; Jiao L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):35-40. PubMed ID: 29595455
[TBL] [Abstract][Full Text] [Related]
6. Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx.
Song N; Jiang H; Wang J; Xie JX
J Neurosci Res; 2007 Nov; 85(14):3118-26. PubMed ID: 17663481
[TBL] [Abstract][Full Text] [Related]
7. Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study.
He Y; Thong PS; Lee T; Leong SK; Shi CY; Wong PT; Yuan SY; Watt F
Brain Res; 1996 Sep; 735(1):149-53. PubMed ID: 8905180
[TBL] [Abstract][Full Text] [Related]
8. Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study.
Oestreicher E; Sengstock GJ; Riederer P; Olanow CW; Dunn AJ; Arendash GW
Brain Res; 1994 Oct; 660(1):8-18. PubMed ID: 7828004
[TBL] [Abstract][Full Text] [Related]
9. Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1.
Jia W; Xu H; Du X; Jiang H; Xie J
Neurobiol Aging; 2015 Feb; 36(2):1183-93. PubMed ID: 25467637
[TBL] [Abstract][Full Text] [Related]
10. Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease.
Grolez G; Moreau C; Sablonnière B; Garçon G; Devedjian JC; Meguig S; Gelé P; Delmaire C; Bordet R; Defebvre L; Cabantchik IZ; Devos D
BMC Neurol; 2015 May; 15():74. PubMed ID: 25943368
[TBL] [Abstract][Full Text] [Related]
11. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
12. Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease.
Ayton S; Lei P; Adlard PA; Volitakis I; Cherny RA; Bush AI; Finkelstein DI
Mol Neurodegener; 2014 Jul; 9():27. PubMed ID: 25011704
[TBL] [Abstract][Full Text] [Related]
13. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
Konieczny J; Czarnecka A; Kamińska K; Lenda T; Nowak P
Behav Brain Res; 2015 Apr; 283():203-14. PubMed ID: 25655509
[TBL] [Abstract][Full Text] [Related]
14. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
[TBL] [Abstract][Full Text] [Related]
15. Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease.
Zhu Y; Wang B; Tao K; Yang H; Wang Y; Zhou T; Yang Y; Yuan L; Liu X; Duan Y
Parkinsonism Relat Disord; 2017 Mar; 36():76-82. PubMed ID: 28108264
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.
Iczkiewicz J; Rose S; Jenner P
Exp Neurol; 2007 Sep; 207(1):95-106. PubMed ID: 17643430
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
18. Subthalamic nucleus lesioning inhibits expression and phosphorylation of c-Jun in nigral neurons in the rat's 6-OHDA model of Parkinson's disease.
Winter C; Hosmann K; Harnack D; Meissner W; Paul G; Morgenstern R; Kupsch A
Synapse; 2006 Jul; 60(1):69-80. PubMed ID: 16598703
[TBL] [Abstract][Full Text] [Related]
19. Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning.
He Y; Lee T; Leong SK
Free Radic Res; 1999 Aug; 31(2):103-12. PubMed ID: 10490239
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between iron levels and degeneration of dopaminergic neurons in rat nigrostriatal system during the early 6-OHDA lesions in medial forebrain bundle].
Wang J; Jiang H; Xie JX
Sheng Li Xue Bao; 2003 Aug; 55(4):422-7. PubMed ID: 12937822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
